[
  {
    "id": 191883,
    "title": "supplemental data lecanemab",
    "slug": "supplemental-data-lecanemab",
    "status": "submitted",
    "embargo_status": "public",
    "user": 7386,
    "username": "jeanne.lenzer@gmail.com",
    "agency": 116,
    "datetime_submitted": "2025-08-24T08:38:24.827709",
    "date_due": "2025-09-22",
    "days_until_due": null,
    "date_followup": null,
    "datetime_done": null,
    "datetime_updated": "2025-08-24T08:38:24.957501",
    "date_embargo": null,
    "tracking_id": "",
    "price": "0.00",
    "disable_autofollowups": false,
    "tags": [],
    "communications": [
      {
        "foia": 191883,
        "from_user": 7386,
        "to_user": 9582,
        "subject": "",
        "datetime": "2025-08-24T08:38:24.957501",
        "response": false,
        "autogenerated": false,
        "thanks": false,
        "full_html": false,
        "communication": "To Whom It May Concern:\r\n\r\nPursuant to the Freedom of Information Act, I hereby request the following records:\r\n\r\nAugust 24, 2025\r\nFood and Drug Administration\r\nDivision of Freedom of Information (HFI-35)\r\n\r\nRE: Freedom of Information Act request\r\n\r\nDear FOIA Officer:\r\n\r\nPursuant to the Freedom of Information Act, 5 U.S.C. \u00a7 552a, I am requesting all materials responsive to the supplemental approvals, numbers 1, 5, 8 and 13 for lecanemab/Leqembi. This should include all updated efficacy and safety study data and reviews by FDA for each supplemental approval. \r\n\r\nI am a professional journalist writing for The BMJ and The Lever, an online investigative outlet. \r\n\r\nAs an investigative journalist, I request a waiver of fees associated with processing this FOIA request and duplicating responsive records.\r\n\r\nThank you for your attention to this request.\r\n\r\nSincerely,\r\nJeanne Lenzer\r\n\r\nThe requested documents will be made available to the general public, and this request is not being made for commercial purposes.\r\n\r\nIn the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.\r\n\r\nThank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.\r\n\r\nSincerely,\r\n\r\nJeanne Lenzer",
        "status": null,
        "likely_foia": null,
        "files": [],
        "delivered": "none"
      }
    ],
    "absolute_url": "https://www.muckrock.com/foi/united-states-of-america-10/supplemental-data-lecanemab-191883/"
  }
]